Stay updated with breaking news from Stephen Yoder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON, MA / ACCESSWIRE / March 27, 2024 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) provided a corporate update today announcing a strategy to maximize its ability to capture the potential milestones
Haley -- in a surprise to many -- made out the GOP to be the wicked earmark kings of Congress, while admitting that Democrats were relatively frugal.
Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring BOSTON,MA, July 18, 2023 - Pieris Pharmaceuticals, Inc. , a clinical-stage biotechnology company...
Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring ...
Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep Due to New Non-Clinical Safety Findings From 13-week Toxicology Study BOSTON,MA,... | June 21, 2023